Fulgent Genetics Inc (FLGT) — Cash Flow-to-Debt Ratio
Fulgent Genetics Inc (FLGT) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of $7.10 Million could theoretically repay 0% of its total liabilities ($112.22 Million) in one year. See Fulgent Genetics Inc (FLGT) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Fulgent Genetics Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Fulgent Genetics Inc across 12 annual periods. Also explore Fulgent Genetics Inc (FLGT) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Fulgent Genetics Inc (2014–2025)
Year-by-year debt coverage analysis for Fulgent Genetics Inc. For market capitalisation and broader financial context, see market value of Fulgent Genetics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.95x | $-101.64 Million | $106.81 Million | ▼ -510.3% |
| 2024 | 0.23x | $21.06 Million | $90.81 Million | ▼ -12.4% |
| 2023 | 0.26x | $27.00 Million | $102.04 Million | ▼ -87.9% |
| 2022 | 2.18x | $253.52 Million | $116.18 Million | ▼ -54.3% |
| 2021 | 4.77x | $538.58 Million | $112.84 Million | ▲ +344.9% |
| 2020 | 1.07x | $140.63 Million | $131.07 Million | ▲ +16.3% |
| 2019 | 0.92x | $5.52 Million | $5.98 Million | ▲ +475.2% |
| 2018 | -0.25x | $-675.00K | $2.75 Million | ▼ -154.0% |
| 2017 | 0.46x | $1.33 Million | $2.92 Million | ▼ -63.2% |
| 2016 | 1.24x | $4.41 Million | $3.56 Million | ▲ +187.6% |
| 2015 | -1.41x | $-969.00K | $686.00K | ▲ +86.0% |
| 2014 | -10.08x | $-4.40 Million | $436.00K | — |